Korro Bio, Inc. (KRRO) Financials

KRRO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 163.4 million 60.2 million
March 31, 2026 183.6 million 64.0 million
Dec. 31, 2025 113.5 million 62.1 million
Sept. 30, 2025 161.6 million 62.5 million

KRRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -17.0 million 2.7 million
March 31, 2026 -16.1 million 2.7 million
Dec. 31, 2025 -17.8 million 2.1 million
Sept. 30, 2025 -17.4 million 1.8 million

KRRO Net Income

No data available :(

KRRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 115.0 million - 42.2 million
March 31, 2026 114.0 million - 42.9 million
Dec. 31, 2025 75.2 million - 43.5 million
Sept. 30, 2025 93.5 million - 41.5 million

KRRO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 17.6 million
March 31, 2026 11.6 million
Dec. 31, 2025 9.4 million
Sept. 30, 2025 9.4 million

KRRO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 37000 13.6 million 6.5 million -
March 31, 2026 21000 13.0 million 7.5 million -
Dec. 31, 2025 84000 11.0 million 6.2 million -
Sept. 30, 2025 175000 13.8 million 6.5 million -

KRRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 380000
Dec. 31, 2025 1.3 million 649000
Sept. 30, 2025 1.1 million -

KRRO

Price: $13.18

52 week price:
5.20
55.89

Earnings Per Share: -9.76 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 193.5 million

Links: